dismiss

Get a Free 3-Day Pass to AAMI 2014 in Philadelphia, May 31-June 2 -- Visit DOTmed, Booth 231

SEARCH

Current Location: DOTmed News > Industry Headlines > This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

More Industry Headlines

FDA clears new CT system from Siemens Ideal for challenging cases.

CT can detect arterial plaque for diabetics CCTA is a welcome development.

Gov. Jan Brewer signs breast density law Arizona becomes the latest state with inform legislation.

Goggles that illuminate cancer cells Could they reduce second surgeries?

Philips suspends CT and PET/CT production at Ohio facility Setback for customers and the company.

Varian's seven year patent dispute comes to an end Company will pay about $35 million.

FDA OKs GE's new CT scanner Ideal for challenging cases.

MRI technique can help treat concussion patients Measures white brain matter damage.

What's the big-picture impact of HIT on health care? Q&A with thought leader Bipin Thomas.

Special report: Contrast media One size does not fit all.

George Morgan is vRad's new CEO.

vRad names US Oncology exec CEO

by Brendon Nafziger , DOTmed News Associate Editor
Virtual Radiologic, the country's biggest teleradiology provider, named former US Oncology executive George Morgan its new CEO.

vRad said that starting Tuesday Morgan would step in for departing CEO and president Rob Kill.

Morgan spent the last seven years as chief operating officer with US Oncology, a network of more than 1,000 cancer doctors that was bought by McKesson in 2010. During his tenure, the company's revenues doubled, growing from $1.5 billion to $3 billion, vRad said.

Before joining US Oncology, Morgan led the ambulatory surgical division of the Hospital Corporation of America, vRad said.

vRad runs a network of more than 400 radiologists and also makes workflow and image sharing and storing software. Over the past few years, it has grown quickly, having bought rival teleradiology provider Nighthawk in late 2010.

vRad's outgoing CEO Kill was with the company for five years. His LinkedIn page lists his current position as a board member on an audit committee of Uroplasty Inc., a company that makes neuromodulation products to stop incontinence.
Story Continues Below Advertisement

Click here to Schedule a Demonstration With McKesson

McKesson Enterprise Medical Imaging Solutions Help Enhance Your Financial, Clinical & Operational Effectiveness. Learn more about McKesson solutions for radiology at McKesson.com/medicalimaging



"George is a highly experienced and talented leader who will help vRad achieve its next stage of growth," Eran Broshy, chair of vRad's board of directors, and a senior advisor with the company's primary sponsor, Providence Equity Partners, said in a statement. "We also thank Rob Kill...for his leadership in successfully transitioning vRad from a niche teleradiology provider to the strong market leader it is today."

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED